However, the expression of HER2 was found to be significantly high in DCIS (57.14%) and IDC (41.82%) samples compared to the normal breast tissue samples (12.50%) (P < 0.05). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.